ISTH 2020 Congress
Coagulation and Natural Anticoagulants » FVIII/IX
Theme Navigation
Abstract Number: PB0326
A New Test Set up to Dose Factor VIII Ability to Bind Exogenous VWF
Abstract Number: PB0343
An Overview of Patients with Hemophilia A in China: Epidemiology, Disease Severity, and Treatment Strategies
Abstract Number: PB0348
Analytical Variability (CV) of One Stage Factor VIII Assay: A Quality Control (QC) Experience. Argentinian Group of Biochemists in Hemophilia
Abstract Number: PB0339
aPTT Reaction Curves Provide Important Additional Information in Hemophilia Patients
Abstract Number: PB0347
B Cell Cytokines in Italian Hemophilia A Patients with Inhibitors
Abstract Number: PB0322
Bleeds and Imaging Scores in Relation to Pharmacokinetics of Coagulation Factor VIII in Chinese Pediatric Patients with Severe Hemophilia A
Abstract Number: PB0324
Comparative Analysis of the Coagulometric and Chromogenic Methods for the Determination of Factor VIII Activity in the Plasma of Patients Suspected with Blood Coagulation Disorders
Abstract Number: PB0319
Comparative Pharmacokinetics of Two Recombinant FVIII Concentrates in Chinese Pediatric Patients with Severe Hemophilia A: A Single-Center Study
Abstract Number: PB0344
Detection and Quantification of F8 Inv1 and Inv22 Inversions Using Digital Droplet PCR and Mile-post Assays
Abstract Number: PB0350
Development and Performance Characterization of an Automated Chromogenic Assay for Human Factor IX Activity
Abstract Number: PB0330
Difference Molecular Profiles of Type 1 and 2 Inhibitor Developed in Mild/Moderate Hemophilia A
Abstract Number: PB0323
Emicizumab Treatment in Pediatric Patients with Hemophilia A without Inhibitors: A Single-Institution Study
Abstract Number: PB0341
Evaluation of Coagulation FIX Binding to Collagen IV and the Impact on Thrombin Generation
Abstract Number: PB0335
Evaluation of Structurally Altered Protein in Factor VIII Therapeutic Products Using Chromatography on Immobilized von Willebrand Factor
Abstract Number: PB0342
Evaluation of the Effect Emicizumab Neutralizing Antibodies on aPTT Clotting-based Tests Results in Patients Treated with Emicizumab
Abstract Number: PB0328
FVIII Gene Mutation Analysis and Evaluation of Clinical Data: One Center Result
Abstract Number: PB0321
Identification of a Novel “Laminin G” Domain Mutant of Protein S Defective in Binding and Inhibiting FIXa and Unaffected in APC/TFPI Cofactor Activities
Abstract Number: PB0329
Identification of Zebrafish Orthologue to Human Factor IX Gene and its Age Dependent Regulation